Title(s): NSABP B-43. A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
Investigator(s):
Andrew Fenton, MD
Contact
Information:
McDowell Cancer Research 330-344-6348
Title(s): RTOG 1014. A Phase II Study of Repeat Breast Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation (PBrl) for Local Recurrence of Breast Carcinoma.
Investigator(s):
Mitchel Fromm, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): CTSU SCUSF 0806. Phase II Placebo-Controlled Trial of Lisinopril and Coreg CR to Reduce Cardiotoxicity in Patients with Breast Cancer Receiving (neo) Adjuvant Chemotherapy with Trastuzumab (Herceptin)
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): SWOG 1007. A Phase II Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or less
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): CTSU E2108. A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): SWOG 0812. A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of High Dose Vitamin D in Premenopausal Women at High-Risk for Breast Cancer, Phase IIB
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): NSABP B-49. A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
Investigator(s):
Andrew Fenton, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): SWOG 1105. Randomized Trial of Text-Messaging Intervention to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy In Women With Early Stage Breast Cancer
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): RTOG 1119. Phase II Randomized Study Of Whole Brain Radiotherapy In Combination With Concurrent Lapatinib In Patients With Brain Metastasis From HER2-Positive Breast Cancer- A COLLABORATIVE STUDY OF RTOG AND KROG.
Investigator(s):
Mitchel Fromm, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): SWOG 1207. Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): RTOG 1005. A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer
Investigator(s):
Mitchel Fromm, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
